Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rawcliffe Adrian Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 45,000 options to buy @ $4.58, valued at $206.1k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 13,042 shares @ $1.7468, valued at $22.8k
Sold 18,763 shares @ $1.706, valued at $32k
01/04/2023 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 5,073 shares @ $1.694, valued at $8.6k
09/01/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 2,536 shares @ $1.9689, valued at $5k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 2,562 shares @ $1.63, valued at $4.2k
01/18/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 11,096 shares @ $3.1918, valued at $35.4k
01/13/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 14,362 shares @ $3.5567, valued at $51.1k
Sold 3,046 shares @ $3.5441, valued at $10.8k
01/13/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 4,690,224 options to buy @ $0
Granted 1,047,480 options to buy @ $0
01/05/2022 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 5,532 shares @ $4.0642, valued at $22.5k
09/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 42,000 options to buy @ $5.97, valued at $250.7k
06/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2020 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 2,776 shares @ $8.5149, valued at $23.6k
08/20/2020 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 10,500 options to buy @ $9.13, valued at $95.9k
08/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2020 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 2,515,536 options to buy @ $0
Granted 561,792 options to buy @ $0
01/15/2020 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 3,236 shares @ $5.1347, valued at $16.6k
01/07/2020 4 Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 5,900 shares @ $1.2, valued at $7.1k
09/03/2019 4 Rawcliffe Adrian (CEO and CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 628,872 options to buy @ $0
Granted 140,448 options to buy @ $0
08/16/2019 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 10,500 options to buy @ $20.34, valued at $213.6k
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/16/2019 4 Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 3,084 shares @ $5.3694, valued at $16.6k
01/08/2019 4 Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 1,257,744 options to buy @ $0
Granted 280,896 options to buy @ $0
08/15/2018 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 9,000 options to buy @ $46.7, valued at $420.3k
03/22/2018 4 Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 600,000 shares @ $1.71, valued at $1M
01/17/2018 4 Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 687,984 options to buy @ $0
Granted 153,648 options to buy @ $0
08/17/2017 4 Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 9,000 options to buy @ $18.1, valued at $162.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy